Brokerages Set Intuitive Surgical, Inc. (NASDAQ:ISRG) Price Target at $609.83

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have been assigned a consensus recommendation of “Moderate Buy” from the twenty-seven analysts that are covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation, sixteen have assigned a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $611.0833.

A number of research firms have recently weighed in on ISRG. Citigroup downgraded shares of Intuitive Surgical from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $650.00 to $635.00 in a report on Thursday, December 11th. Leerink Partners boosted their price objective on Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 22nd. Jefferies Financial Group upped their price objective on Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a research report on Wednesday, October 22nd. UBS Group set a $600.00 target price on Intuitive Surgical and gave the stock a “neutral” rating in a report on Thursday, October 23rd. Finally, Mizuho set a $575.00 price target on Intuitive Surgical in a report on Wednesday, October 22nd.

Insiders Place Their Bets

In related news, SVP Mark Brosius sold 464 shares of the stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $548.49, for a total value of $254,499.36. Following the sale, the senior vice president directly owned 131 shares of the company’s stock, valued at $71,852.19. This represents a 77.98% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Craig H. Barratt sold 750 shares of the firm’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $435,000.00. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 114,007 shares of company stock valued at $63,533,844. 0.70% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Intuitive Surgical

Several hedge funds and other institutional investors have recently modified their holdings of the business. Vanguard Group Inc. grew its position in Intuitive Surgical by 0.8% in the 3rd quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock valued at $15,026,776,000 after acquiring an additional 263,828 shares during the last quarter. State Street Corp grew its stake in Intuitive Surgical by 1.2% in the second quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock worth $8,451,223,000 after purchasing an additional 182,871 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Intuitive Surgical by 1.4% during the 2nd quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock worth $4,429,590,000 after buying an additional 109,904 shares in the last quarter. Capital World Investors grew its holdings in Intuitive Surgical by 1.5% during the 3rd quarter. Capital World Investors now owns 7,728,492 shares of the medical equipment provider’s stock worth $3,456,223,000 after acquiring an additional 116,034 shares in the last quarter. Finally, Norges Bank purchased a new position in Intuitive Surgical during the 2nd quarter valued at about $2,569,260,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $572.47 on Thursday. The company has a market cap of $205.22 billion, a price-to-earnings ratio of 75.72, a PEG ratio of 5.26 and a beta of 1.68. Intuitive Surgical has a 1 year low of $425.00 and a 1 year high of $616.00. The stock’s 50 day simple moving average is $541.48 and its two-hundred day simple moving average is $505.98.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. The company had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. Intuitive Surgical’s quarterly revenue was up 22.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.84 earnings per share. As a group, analysts anticipate that Intuitive Surgical will post 6.43 EPS for the current year.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Truist raised its price target to $650 and maintains a Buy rating — the upgrade gives visible upside and likely underpins analyst-driven buying interest. Read More. Read More.
• Positive Sentiment: RBC publishes a bullish forecast and RBC Capital keeps an Outperform rating — another large broker calling for strong price appreciation, supporting momentum. Read More. Read More.
• Positive Sentiment: Robert W. Baird reaffirmed its Buy rating — adds to the cluster of brokerages staying constructive, which can sustain inflows. Read More.
• Positive Sentiment: ISRG received a mention on CNBC’s “Final Trades” — media highlights can drive short-term retail/intraday interest. Read More.
• Neutral Sentiment: Company reorganized its digital and AI leadership (effective Jan 1) — signals focus on software/AI strategy but execution and timing are uncertain. Read More.
• Neutral Sentiment: ISRG plans to move to direct distribution in Southern Europe in 2026 to capture distributor economics — could lift margins if executed well, but the analyst note flags execution risk. Read More.
• Neutral Sentiment: Analyst consensus remains a “Moderate Buy” across brokerages — broad support, but not unanimous conviction; reinforces the view of steady analyst backing. Read More.
• Negative Sentiment: Valuation questions after a ~27% three‑month share-price climb — coverage is asking whether ISRG is still undervalued, raising the risk of short-term profit-taking given elevated multiples. Read More.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.